Cohance Lifesciences Limited (BOM:543064)
India flag India · Delayed Price · Currency is INR
879.35
+9.10 (1.05%)
At close: Aug 29, 2025

Cohance Lifesciences Revenue

Cohance Lifesciences had revenue of 5.49B INR in the quarter ending June 30, 2025, with 138.12% growth. This brings the company's revenue in the last twelve months to 12.59B, up 34.71% year-over-year. In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B with 13.91% growth.

Revenue (ttm)
12.59B
Revenue Growth
+34.71%
P/S Ratio
26.76
Revenue / Employee
10.55M
Employees
1,193
Market Cap
336.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202511.98B1.46B13.91%
Mar 31, 202410.51B-2.89B-21.56%
Mar 31, 202313.40B201.07M1.52%
Mar 31, 202213.20B3.11B30.75%
Mar 31, 202110.10B1.76B21.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reliance Industries9,765.41B
HDFC Bank2,736.06B
Tata Consultancy Services2,561.48B
Bharti Airtel1,839.41B
ICICI Bank2,054.85B
State Bank of India3,503.84B
Hindustan Unilever639.28B
Infosys1,672.76B
Revenue Rankings